• Skip to main content
  • Skip to header right navigation
  • Skip to after header navigation
  • Skip to site footer
  • Facebook
  • Instagram
  • Contact Us
  • Donate
  • Home
    • Newsletters
    • Personal Stories
    • Support Articles
  • Medical Information
    • Conferences
    • Grant Funding
  • Support CBTF
    • CBTF Board and Advisors
    • CBTF Sponsors & Partnerships
  • Home
  • Patients and Families
    • Childhood Brain Tumor Updates
    • Newsletters
    • Personal Stories
    • Support Articles
  • Medical Information
    • Childhood Brain Tumor Updates
  • Research
    • Conferences
    • Grant Funding
    • Research Links
  • Support CBTF
    • Geoff Cornman Memorial Golf Tournament
  • About CBTF
    • CBTF Board and Advisors
    • CBTF Sponsors & Partnerships

Grant Summaries

Role of MicroRNA Regulatory Networks in Pediatric Pilocytic Astrocytoma

09/01/2014 by Jeanne Young

Fausto J. Rodriguez, M.D., Johns Hopkins University School of Medicine Progress Update: One-year funding, 9/2013-8/2014 The main goal of this proposal is to compare changes in the abundance of a group of molecules that have been recently discovered and named “microRNAs” in pilocytic astrocytoma (PA), the most frequent low grade glioma in children. MicroRNAs are …

Read moreRole of MicroRNA Regulatory Networks in Pediatric Pilocytic Astrocytoma

Targeting the MPS1 Kinase for Medulloblastoma Therapy

08/01/2014 by Jeanne Young

Rajeev Vibhaker, M.D., Ph.D. University of Colorado Progress Update: 9/2012-8/2014 We have completed the initial set of studies to examine the role of MPS1 in controlling medulloblastoma cell division and validated a therapeutic target. We demonstrated that MPS1 is critical for cell division of tumor cells and both genetic and chemi-cal inhibition of MPS1. Several …

Read moreTargeting the MPS1 Kinase for Medulloblastoma Therapy

BRaf Mutation Effects on Asymmetric Division in Malignant Astrocytoma

02/01/2014 by Jeanne Young

Claudia Petritsch, Ph.D., The Regents of the University of California Funding duration 2012-2014, Program Summary Studies have shown that a mutant activated form of BRAF, BRAFV600E, and concomitant homozygous deletion of CDKN2A occur in a  subset of pediatric malignant astrocytomas.  Importantly, BRAFV600E transforms CDKN2A-deficient neural progenitor cells and BRAF kinase is involved in signaling pathways …

Read moreBRaf Mutation Effects on Asymmetric Division in Malignant Astrocytoma

Evaluating the efficacy of Casein Kinase 1 Agonists on Medulloblastoma Recurrence

09/23/2013 by Jeanne Young

Jezabel Rodriguez-Blanco, Ph.D. Postdoctorate Associate, Molecular Oncology The DeWitt Daughtry Family Department of Surgery Progress Update: 9/2013-8/2015 Medulloblastoma (MB) is a highly malignant brain tumor affecting predominantly children. MB arises from granular progenitors that after cerebella development do not respond to cellular cues to stop functioning, resulting in them becoming cancer stem/progenitor cells (CSC) that …

Read moreEvaluating the efficacy of Casein Kinase 1 Agonists on Medulloblastoma Recurrence

The Short and Long-term Effects of Biological Agents on Oligodendrocyte Lineage and Progenitor Cells in Developing Brain

09/15/2013 by Jeanne Young

PI:  Joseph Scafidi, DO – Children’s Research Institute, Washington, DC Grant duration, Aug. 2011 – Sept. 2013, review is update on progress The brain of children is subject to rapid growth and development. White matter is the part of the brain that is vital for communication and processing of information. White matter comprises nearly half …

Read moreThe Short and Long-term Effects of Biological Agents on Oligodendrocyte Lineage and Progenitor Cells in Developing Brain

A Physical Activity Intervention to Improve Cognitive Effects in Children with Brain Tumors

07/01/2013 by Jeanne Young

Pamela L. Wolters, Ph.D., Neurobehavioral Program, National Cancer Institute Program duration 2012-2013, one-year Significant cognitive late effects are associated with cranial radiation therapy.  Although treatment regimens have been modified in attempts to reduce neurotoxicity, limited research has focused on therapeutic interventions targeted toward ameliorating or preventing these impairments.  One potential novel intervention for cognitive rehabilitation …

Read moreA Physical Activity Intervention to Improve Cognitive Effects in Children with Brain Tumors

IMP3 protein expression is a potential independent prognostic factor in pediatric PILOCYTIC and pilomyxoid astrocytoma.

09/01/2012 by Jeanne Young

Sarah Rush, University of Colorado 2012, Summary research update Pediatric pilocytic and pilomyxoid astrocytomas are slow growing and amenable to surgical cure if located in a favorable place. However, a significant number of children (> 55 %) will eventually suffer from tumor progression. Although this tumor is unlikely to become a more aggressive astrocytoma, repeated …

Read moreIMP3 protein expression is a potential independent prognostic factor in pediatric PILOCYTIC and pilomyxoid astrocytoma.

Clinical and biological relevance of PI3K/AKT/mTOR Pathway activation in pilocytic astrocytoma

06/01/2012 by Jeanne Young

Fausto J. Rodriguez M.D., Johns Hopkins School of Medicine Report from funding, 2011-2012. This study has been published in two journals. Pilocytic astrocytomas (PA) are low grade neoplasms that represent the most frequent gliomas in children and your adults. Most of these tumors have an excellent outcome after gross total resection. However a subset progress …

Read moreClinical and biological relevance of PI3K/AKT/mTOR Pathway activation in pilocytic astrocytoma

Validation of IMPS as a prognostic marker in juvenile pilocytic astrocytoma

10/15/2011 by Jeanne Young

Sarah Rush, M.D., University of Denver Two-year funding, 2010-2011 Juvenile pilocytic astrocytomas (JPA) are common tumors of childhood.  Despite the high incidence, the biological factors that influence outcomes for these children remain poorly understood. Based on our preliminary data, IMP3 represents a highly specific prognostic marker for JPA allowing for improved prediction of outcome. The aim …

Read moreValidation of IMPS as a prognostic marker in juvenile pilocytic astrocytoma
  • Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next

The Childhood Brain Tumor Foundation

“Together, Reaching for a Cure”

301-515-2900 or 877-217-4166

CBTF Sponsors and Partners

Surgical Theater
FD Associates-CBTF Sponsor
Run with the Saints Houston, TX event

If you are interested in becoming a Sponsor or Partner of CBTF,

please contact us. Thank you!

  • Mail
  • Facebook
  • Instagram

Copyright © 2025 · The Childhood Brain Tumor Foundation · All Rights Reserved · Web Design by Wood WEB Worx